Internal Medicine, Endocrinology, Diabetes, & Metabolism · Rancho Mirage, CA
NPI
1710214218
Since 2009
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
2
Medicare group memberships
Hospitals
5
Hospital affiliations
39000 Bob Hope Dr
Rancho Mirage, CA, 92270
Phone (760) 834-7966
Groups this clinician bills Medicare through
Medicare paid, 2024
$192K
4,906 services
Medicare patients, 2024
1,047
Average age 71
Drug cost, 2024
$5.7M
11,850 prescriptions
Company payments, 2025
$1,453
From 20 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Chadi Richeh was code 99214 (office e&m - established), 1,498 times for 863 patients. In total Chadi Richeh billed 4,906 services in 60 codes, and Medicare paid $192K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-05-20.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 1,498 | 863 | $90.59 | $136K |
| 36415 Venipuncture Blood Collection | Office | 1,298 | 782 | $7.78 | $10K |
| J0897 Injection, denosumab, 1 mg | Office | 720 | 11 | $19.46 | $14K |
| 83036 Blood Count | Office | 562 | 371 | $9.31 | $5,230 |
| 99204 Office E&M - New | Office | 154 | 154 | $118.46 | $18K |
| 80053 Clinical Chemistry | Office | 68 | 45 | $8.93 | $607 |
| G0108 Diabetes outpatient self-management training services, individual, per 30 minutes | Office | 60 | 24 | $44.80 | $2,688 |
| 96372 Injection Administration | Office | 59 | 17 | $10.44 | $616 |
| 84481 Clinical Chemistry | Office | 36 | 27 | $12.32 | $444 |
| 84439 Clinical Chemistry | Office | 36 | 27 | $6.45 | $232 |
| 84443 Clinical Chemistry | Office | 31 | 25 | $13.04 | $404 |
| 80061 Clinical Chemistry | Office | 25 | 20 | $10.51 | $263 |
| 82043 Clinical Chemistry | Office | 21 | 16 | $4.51 | $94.71 |
| 99442 Telephone Services | Office | 17 | 15 | $42.49 | $722 |
| 82306 Clinical Chemistry | Office | 16 | 13 | $23.47 | $375 |
By year: 2022 $236K for 8,083 services; 2023 $246K for 10,902 services; 2024 $192K for 4,906 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 1,298 | 782 | $7.78 | $10K |
| 83036 Blood Count | 562 | 371 | $9.31 | $5,230 |
| 80053 Clinical Chemistry | 68 | 45 | $8.93 | $607 |
| 84481 Clinical Chemistry | 36 | 27 | $12.32 | $444 |
| 84439 Clinical Chemistry | 36 | 27 | $6.45 | $232 |
| 84443 Clinical Chemistry | 31 | 25 | $13.04 | $404 |
| 80061 Clinical Chemistry | 25 | 20 | $10.51 | $263 |
| 82043 Clinical Chemistry | 21 | 16 | $4.51 | $94.71 |
| 82306 Clinical Chemistry | 16 | 13 | $23.47 | $375 |
Medicare prescription drug claims, 2024
In 2024, the drug Chadi Richeh prescribed most often to Medicare patients was Levothyroxine Sodium, with 1,677 prescriptions and refills. In total Chadi Richeh wrote 11,850 Medicare prescriptions that cost $5.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 1,677 | 4,527 | 513 | $19K |
| Ozempic Semaglutide | 740 | 1,185 | 181 | $1.1M |
| Mounjaro Tirzepatide | 505 | 684 | 116 | $716K |
| Metformin Hcl Generic | 400 | 1,066 | 138 | $3,865 |
| Tresiba Flextouch U-100 Insulin Degludec | 380 | 945 | 153 | $421K |
| Glipizide Er Glipizide | 362 | 1,062 | 139 | $6,938 |
| Metformin Hcl Er Metformin Hcl | 350 | 883 | 136 | $3,874 |
| Synthroid Levothyroxine Sodium | 307 | 795 | 95 | $26K |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 279 | 702 | 125 | $60K |
| Atorvastatin Calcium Generic | 248 | 677 | 85 | $2,723 |
| Jardiance Empagliflozin | 227 | 465 | 68 | $264K |
| Toujeo Solostar Insulin Glargine,hum.Rec.Anlog | 213 | 486 | 78 | $276K |
| Pioglitazone Hcl Generic | 198 | 531 | 74 | $2,927 |
| Glipizide Generic | 184 | 529 | 68 | $2,368 |
| Lisinopril Generic | 169 | 441 | 53 | $1,229 |
Brand drugs: 5,670 claims; generic drugs: 5,218 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Chadi Richeh $1,453 ($1,453 in general payments such as food, travel and fees) from 20 companies. The largest payer was Novo Nordisk Inc with $320.
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc NVO | 21 | $320 |
| Amgen Inc. AMGN | 14 | $266 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 6 | $131 |
| Lilly USA, LLC LLY | 6 | $114 |
| Beta Bionics, Inc. BBNX | 1 | $110 |
| Corcept Therapeutics CORT | 4 | $74.21 |
| Abbvie Inc. ABBV | 3 | $55.97 |
| Soleno Therapeutics, Inc. SLNO | 2 | $50.98 |
| Insulet Corporation PODD | 2 | $46.79 |
| Novartis Pharmaceuticals Corporation NVS | 2 | $42.27 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.